Adamant Biomedical Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	$2.23M	Hold	23,000	–	–	0.53%	61
2014 Q3	$1.8M	Buy	+23,000	New	+$1.8M	0.45%	63